The first part of an end-of-the-year review of LCGC International’s editorial coverage of HPLC 2025, which took place in Bruges from 19–23 June 2025 .

EFLM recognizes Babson Diagnostics for innovations in sample collection and preparation AUSTIN, TX / ACCESS Newswire / ...

Abstract: We propose a novel ensemble learning method based on sample complementarity that considers sample complementarity through scientific model selection and weight allocation. Our approach aims ...

Research posters should be more than academic advertisements—or, conversely, overwhelming data dumps that attempt to compress ...

If you’re somewhat like me and spend time scrolling on Instagram, you must have stumbled upon those stylish hand made posters that are suddenly everywhere. They look so real that they may send you ...

HENDERSON, Ky. (WEHT) — Two USI students have been recognized at an international supercomputing conference in St. Louis. According to the university, students Alyson Collins and Maya Seshan were ...

Two students from P.D.A. College of Engineering, Kalaburagi, have won the Best Poster Award at an international conference held at the Indian Institute of Technology Bombay (IIT Bombay). Shekhar ...

Start by reading this document. Thank you for your interest in presenting at KSU Analytics Day on Friday, November 21, 2025. Presentations are scheduled from 7:30am until 10:55am. Presenters will ...

SAN JOSE, Calif., Oct. 23, 2025 /PRNewswire/ -- BridGene Biosciences, Inc., a leader in the discovery of small molecule drugs for traditionally "hard-to-drug" targets, announced today that three ...

Getting an abstract into the annual conference for the Congress of Neurological Surgeons, a professional organization for neurosurgeons, is no easy feat for residents or attending physicians. An ...

Cyclin D1 is overexpressed in certain solid tumors and hematologic malignancies. In these cancers, the cyclin D1/CDK4 complex drives cell proliferation by binding to the tumor suppressor ...

SOUTH SAN FRANCISCO, Calif., Oct. 13, 2025 (GLOBE NEWSWIRE) -- BridgeBio Oncology Therapeutics, Inc. (“BBOT”) (Nasdaq: BBOT), a clinical-stage biopharmaceutical company focused on RAS-pathway ...